#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scedosporium infection Squamous cell carcinoma of the oral cavity Prolymphocytic leukaemia Spina bifida Angiosarcoma Mantle cell lymphoma recurrent Squamous cell carcinoma of the hypopharynx Mycobacterium abscessus infection Astrocytoma malignant Neuroendocrine carcinoma Myxofibrosarcoma Anaplastic thyroid cancer Pulmonary hypertension Restless legs syndrome Ductal adenocarcinoma of pancreas More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Trials in Disease Mucous membrane pemphigoid – Trials in Disease Haemophilia B with anti factor IX – Life with Disease Adrenogenital syndrome – Diagnostics Atypical haemolytic uraemic syndrome – Life with Disease Hairy cell leukaemia – Diagnostics Usher’s syndrome – Trials in Disease Breast angiosarcoma Medulloblastoma recurrent – Trials in Disease Synovial sarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mps-106 Duvakitug Povetacicept Brigatinib Izorlisib Mesilate Elebsiran Anitocabtagene Autoleucel Ds-2325A Ontasameran Rugonersen Tirbanibulin ANOC-001 Cobamamide OBI-821 Secale Cereale Acp-204 Tartrate Sodium Zirconium Cyclosilicate Tezepelumab 7-Ethyl-10-Hydroxycamptothecin Ltx-315 More therapies…

    Learn about Your Condition

    Infant sedation Angelman's syndrome Myocardial ischaemia Renal cancer recurrent Primary myelofibrosis Bone marrow disorder Noninfective chorioretinitis Cerebral amyloid angiopathy White matter lesion Skin cancer Pulmonary embolism B-cell lymphoma recurrent Rectal adenocarcinoma Patent ductus arteriosus Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Transitional cell cancer of the renal pelvis and ureter
    • Cervix carcinoma
    Investigated Drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain

  • Study of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Tiragolumab
    • Atezolizumab
    France Spain

  • Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Austria Bulgaria France Germany Italy Poland +1

  • Study Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy The Netherlands +1

  • Study to Compare Fianlimab and Cemiplimab Combination with Cemiplimab Alone for Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    France Greece Romania Spain

  • Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer
    Austria Belgium France Germany Greece Hungary +6
Previous Page
1 … 36 37 38 39 40 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!